WT All Commodities (AIGC.GB) Trades

North Bay Resources CEO Jared Lazerson joined Steve Darling from Proactive to unveil the latest exploration results from the company’s Copper Island Project, following a comprehensive rock sampling program conducted in February 2025. The program targeted eight outcrops within the Pomeroy 1-3, Beaver, and Copper Bell zones, yielding highly promising results. According to Lazerson, assay results revealed copper concentrations as high as 5.69%, along with silver reaching 1 ounce per ton and vanadium at 0.22%. The average assay values stood at 4.6% copper, 0.5 ounces per ton silver, and 0.9% vanadium, further underscoring the project’s potential. Additionally, metallurgical testing indicated that copper mineralization exists in oxide form up to 74.4%, with average oxide copper content of 40.3%, 42.1%, and 58.4% across three different leach tests. This is a crucial finding, as copper in oxide form is typically associated with lower processing costs and higher recovery rates, enhancing the project's economic viability. The Pomeroy 3-4 Zone, one of the most significant areas of interest, exhibits mineralization over a strike length of approximately 750 feet—making it the largest of the numerous copper-silver zones identified to date. The mineralization is associated with a northwest-to-north-trending sequence of amygdaloidal basaltic flows, with key east-west to east-northeast-south-southwest cross-cutting fault and fracture zones contributing to the structural complexity. Multiple parallel mineralized zones have also been identified, further expanding the project's exploration potential. With these encouraging results, North Bay Resources continues to advance its exploration efforts, positioning the Copper Island Project as a compelling opportunity in the copper and critical minerals sector. #proactiveinvestors #northbayresourcesinc #otc #nbri #PlatinumConcentrate #NorthBayResources #MiningNews #CaliforniaGold #JaredLazerson #GoldRush #ProactiveInvestors #PreciousMetals #

Synchronoss Technologies is expanding its cloud offerings with the launch of Capsyl Cloud, a next-generation personal cloud platform designed to help mobile operators and broadband providers quickly deploy secure, scalable, and revenue-generating cloud services. CEO Jeff Miller spoke with Steve Darling from Proactive and the company introduced the new platform at Mobile World Congress in Spain, The company highlighted its potential to transform how users store, manage, and protect their digital content. Capsyl Cloud is a turnkey, cross-platform solution that enables seamless access to photos, videos, documents, audio, contacts, and messages across smartphones, tablets, laptops, and desktops. Unlike traditional storage solutions, Capsyl Cloud leverages AI-powered tools to enhance how users organize, search, and optimize their digital memories. Features include AI-driven photo search capabilities, offering a more intuitive and personalized cloud experience. Developed through extensive beta testing since 2022, Capsyl Cloud is now entering the market with its first major deployment by Telkomsel, Indonesia’s largest mobile network operator. This partnership makes Capsyl Cloud available to millions of Telkomsel’s prepaid and postpaid subscribers, marking a significant milestone in Synchronoss’s strategy to bring innovative cloud solutions to global telecom providers. With Capsyl Cloud, Synchronoss continues to push the boundaries of AI-enhanced cloud technology, providing both users and service providers with a secure, intuitive, and future-ready digital storage solution. #proactiveinvestors #synchronosstechnologiesinc #nasdaq #sncr @cloud #CapsylCloud #AI #MobileWorldCongress #CloudTechnology #MachineLearning #TechInnovation #Telecom #DigitalTransformation #MWC2025

Titan Minerals Ltd CEO Melanie Leighton talked with Proactive about the latest drilling results at the Dynasty Gold Project in southern Ecuador. The company has reported strong extensional drill results, indicating significant growth potential, with mineralisation extending up to 150 metres below the current resource. One standout result includes 17.5 metres at 2.5 g/t gold and 8.6 g/t silver, with a high-grade section of 5 metres at 5.5 g/t gold and 10.7 g/t silver. Leighton highlighted that these results validate Titan’s strategy, confirming that the Dynasty gold system has substantial expansion potential. "Hole CVDD24-122 has been an incredibly successful hole for us," she said. "It has delivered multiple significant intersections from shallow depths while also highlighting the presence of wide, high-grade mineralisation at depth." Titan’s drilling campaign continues at Cerro Verde and other key targets, with assay results pending from several drill holes. Despite temporary weather-related delays, the company remains on track for a Mineral Resource estimate update in mid-2025. For more updates on Titan Minerals’ progress, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe to the channel, and turn on notifications for future updates. #TitanMinerals #ASX #ProactiveInvestors #GoldMining #DynastyGoldProject #MiningNews #Investing #GoldExploration #ResourceExpansion #DrillResults #EcuadorMining #MiningUpdates

Solvonis Therapeutics PLC (LSE:SVNS) non-executive director-elect Dr Renata Crome talked with Proactive about her appointment to the board and what she brings to the company. Dr Crome has an extensive background in pharmaceutical development, having worked at Roche for 30 years. She played a key role in the development of blockbuster treatments such as bevacizumab and obinutuzumab for cancer, as well as Tamiflu for influenza. Following her time at Roche, she transitioned to board roles across commercial and charity organisations and also lectures in pharmaceutical medicine. Discussing her contributions to Solvonis, Dr Crome highlighted her strategic expertise and experience in central nervous system (CNS) treatments. "I have extensive experience in developing treatments in the central nervous system area, and I know the challenges and some of the solutions," she said. She also emphasised her ability to leverage a strong network of experts to support the company's goals. Dr Crome expressed enthusiasm for Solvonis' innovative pipeline and differentiated treatments, as well as the strength of its leadership team. "It’s a privilege to be invited to join them," she said. For more interviews and updates, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for future content. #SolvonisTherapeutics #Pharmaceuticals #Biotech #HealthcareInnovation #Leadership #CNSResearch #DrugDevelopment #Investing #Biopharma #ExecutiveLeadership